BioCentury | Jun 29, 2009
Clinical News

Biovista preclinical data

...In a mouse model of epilepsy, BVA-601 significantly decreased epileptic activity and delayed the onset of...
...epileptic activity and delayed the onset of epileptic seizures compared with diazepam (p<0.05 for both). BVA-601...
...The company expects to begin clinical trials in 2010. Biovista Inc. , Charlottesville, Va. Product: BVA-601...
Items per page:
1 - 1 of 1